Gene-sequencing machine maker Illumina, seeking to build on its strength in DNA sequencing, is launching a new company that will develop and market a test to detect genetic evidence of cancer in the blood.
from WSJ.com: US Business http://ift.tt/1JDXtW4
via IFTTT
No comments:
Post a Comment